Seven Eight Capital’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Seven Eight Capital’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-50,300	Closed	-$2.42M	–	633
2020 Q1	$2.42M	Buy	+50,300	New	+$2.34M	0.62%	34

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Seven Eight Capital's RARX Position: Q2 2020 in Review

Seven Eight Capital sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 50,300 shares — an estimated $2.42M sold.

Seven Eight Capital first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $2.42M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Seven Eight Capital reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Seven Eight Capital sold 50,300 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $2.42M.
Seven Eight Capital first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Seven Eight Capital's Ra Pharmaceuticals, Inc. Common Stock position peaked at $2.42M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Seven Eight Capital's 13F filing for Q2 2020, filed 6 Aug 2020.